| Income Statement |
| Total Revenue | 13.00M |
|
| Revenues (USD) | 13.00M |
| Cost of Revenue | 11.80M |
| Gross Profit | 1.19M |
| Operating Expenses | 1.71M |
| Research and Development Expense | 733.24K |
| Selling, General and Administrative Expense | 976.29K |
| Operating Income | -516.58K |
| Net Income | -538.76K |
| Net Income Common Stock | -538.76K |
| Net Income Common Stock (USD) | -538.76K |
| Consolidated Income | -538.76K |
| Earnings per Basic Share | -0.06 |
| Earnings per Basic Share (USD) | -0.06 |
| Earnings per Diluted Share | -0.06 |
| Earning Before Interest & Taxes (EBIT) | -538.76K |
| Earning Before Interest & Taxes (USD) | -538.76K |
| Weighted Average Shares | 9.15M |
| Weighted Average Shares Diluted | 9.15M |
| Balance Sheet |
| Cash and Equivalents | 671.79K |
| Cash and Equivalents (USD) | 671.79K |
| Trade and Non-Trade Receivables | 1.29M |
| Current Assets | 3.02M |
| Property, Plant & Equipment Net | 320.58K |
| Total Assets | 8.64M |
| Debt Current | 3.87M |
| Total Debt | 4.00M |
| Current Liabilities | 5.04M |
| Debt Non-Current | 129.65K |
| Total Liabilities | 5.17M |
| Accumulated Retained Earnings (Deficit) | -45.27M |
| Accumulated Other Comprehensive Income | 191.82K |
| Shareholders Equity | 3.48M |
| Shareholders Equity (USD) | 3.48M |
| Assets Non-Current | 5.62M |
| Total Debt (USD) | 4.00M |
| Deferred Revenue | 90.08K |
| Goodwill and Intangible Assets | 5.30M |
| Inventory | 151.51K |
| Liabilities Non-Current | 129.65K |
| Trade and Non-Trade Payables | 409.80K |
| Tax Assets | 65.33K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 697.59K |
| Net Cash Flow from Financing | 541.94K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -73.48K |
| Capital Expenditure | -340.00 |
| Issuance (Repayment) of Debt Securities | 541.94K |
| Net Cash Flow from Investing | -1.28M |
| Net Cash Flow from Operations | 661.70K |
| Effect of Exchange Rate Changes on Cash | 5.88K |
| Share Based Compensation | 965.02K |